Detection of cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Cell Line, Tumor Breast Neoplastic Stem Cells Tumor Cells, Cultured Prostate Neoplastic Cells, Circulating Cell Line Feces Lymph Nodes MCF-7 Cells HCT116 Cells HT29 Cells

Organisms4

Mice, Nude Mice, SCID Mice, Inbred BALB C Papillomaviridae

Diseases49

Prostatic Neoplasms Breast Neoplasms Ovarian Neoplasms Lung Neoplasms Stomach Neoplasms Colonic Neoplasms Neoplasm Metastasis Neoplasms Neoplasm Invasiveness Pancreatic Neoplasms Uterine Cervical Neoplasms Genetic Predisposition to Disease Carcinoma Carcinoma, Squamous Cell Colorectal Neoplasms Urinary Bladder Neoplasms Disease Progression Carcinoma, Non-Small-Cell Lung Neoplasm Recurrence, Local Rectal Neoplasms Cell Transformation, Neoplastic Endometrial Neoplasms Esophageal Neoplasms Adenocarcinoma Liver Neoplasms Mouth Neoplasms Head and Neck Neoplasms Precancerous Conditions Carcinoma, Small Cell Skin Neoplasms Bone Neoplasms Neoplasms, Hormone-Dependent Neoplasms, Radiation-Induced Neoplastic Cells, Circulating Neoplasms, Second Primary Neoplasms, Glandular and Epithelial Neovascularization, Pathologic Genital Neoplasms, Female Gastrointestinal Neoplasms Thyroid Neoplasms Papillomavirus Infections Melanoma Mammary Neoplasms, Experimental Pharyngeal Neoplasms Disease Models, Animal Neoplasms, Multiple Primary Carcinoma in Situ Kidney Neoplasms Adenoma

Chemicals and Drugs51

Neoplasm Proteins Cancer Vaccines Tumor Markers, Biological Antineoplastic Agents RNA, Messenger Receptors, Estrogen DNA, Neoplasm Prostate-Specific Antigen Receptor, erbB-2 DNA Primers Antibodies, Monoclonal RNA, Small Interfering Antigens, Neoplasm Tumor Suppressor Protein p53 Fluorouracil Tamoxifen Receptors, Progesterone Cisplatin Antineoplastic Agents, Phytogenic Antineoplastic Agents, Hormonal Anticarcinogenic Agents MicroRNAs Paclitaxel Receptor, Epidermal Growth Factor Reagent Kits, Diagnostic Tumor Suppressor Proteins DNA-Binding Proteins Deoxycytidine Antimetabolites, Antineoplastic DNA Probes Transcription Factors Receptors, Androgen Proto-Oncogene Proteins Carcinogens BRCA2 Protein Nuclear Proteins Taxoids RNA, Neoplasm Carcinoembryonic Antigen DNA Radiopharmaceuticals Antibodies, Monoclonal, Humanized BRCA1 Protein DNA, Bacterial Androgens Estrogens DNA, Viral Proto-Oncogene Proteins c-akt Fluorescent Dyes Biological Markers Protein Kinase Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment86

Early Detection of Cancer Sensitivity and Specificity Limit of Detection Polymerase Chain Reaction Reproducibility of Results Reverse Transcriptase Polymerase Chain Reaction Prognosis Retrospective Studies Prospective Studies Survival Analysis Survival Rate Follow-Up Studies Gene Expression Profiling Risk Antineoplastic Combined Chemotherapy Protocols Neoplasm Staging Predictive Value of Tests Registries Risk Assessment Xenograft Model Antitumor Assays Blotting, Western Enzyme-Linked Immunosorbent Assay Immunoenzyme Techniques Oligonucleotide Array Sequence Analysis Neoplasm Transplantation Mammography Disease-Free Survival Odds Ratio Combined Modality Therapy Risk Factors Chemotherapy, Adjuvant Transplantation, Heterologous Evaluation Studies as Topic Multivariate Analysis Questionnaires Immunoassay Kaplan-Meier Estimate False Positive Reactions Tumor Burden Flow Cytometry Biopsy Real-Time Polymerase Chain Reaction Models, Biological SEER Program Drug Screening Assays, Antitumor Biosensing Techniques Clinical Trials as Topic DNA Mutational Analysis Molecular Diagnostic Techniques Sequence Analysis, DNA Bacteriological Techniques Immunohistochemistry Molecular Targeted Therapy Logistic Models Transfection Reagent Kits, Diagnostic Early Diagnosis Incidence ROC Curve Signal Detection, Psychological Chromatography, High Pressure Liquid Neoplasm Grading Genetic Testing Confidence Intervals Tissue Array Analysis Radiotherapy In Situ Hybridization, Fluorescence Tomography, X-Ray Computed False Negative Reactions Nucleic Acid Amplification Techniques Treatment Outcome Colonoscopy Gene Knockdown Techniques Mammary Neoplasms, Experimental Drug Administration Schedule Disease Models, Animal Positron-Emission Tomography Cluster Analysis Mastectomy Fluorescent Antibody Technique Palliative Care Nucleic Acid Hybridization Specimen Handling Feasibility Studies Prevalence Immunotherapy

Psychiatry and Psychology2

Smoking Signal Detection, Psychological

Phenomena and Processes44

Sensitivity and Specificity Gene Expression Regulation, Neoplastic Mutation Genetic Predisposition to Disease Risk Drug Resistance, Neoplasm Base Sequence Genotype DNA Methylation Odds Ratio Algorithms Cell Survival Time Factors Polymorphism, Genetic Genes, BRCA1 Cell Movement Down-Regulation Dose-Response Relationship, Drug Cell Division Promoter Regions, Genetic Apoptosis Cell Cycle Cell Proliferation Transfection Cell Growth Processes Phenotype Up-Regulation RNA Interference Genes, Tumor Suppressor Germ-Line Mutation Genes, Neoplasm Gene Silencing Gene Expression Alleles Genes, p53 Gene Amplification Postmenopause Diet Signal Transduction Genes, BRCA2 Phosphorylation Nucleic Acid Hybridization Genes, ras DNA Damage

Disciplines and Occupations3

Medical Oncology Immunohistochemistry Virology

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Quality of Life Age Distribution

Humanities1

Quality of Life

Information Science9

Survival Rate Molecular Sequence Data Base Sequence Registries Algorithms Questionnaires SEER Program Incidence Prevalence

Named Groups2

Survivors European Continental Ancestry Group

Health Care35

Sensitivity and Specificity Limit of Detection Reproducibility of Results Retrospective Studies Prospective Studies Survival Analysis Survival Rate Follow-Up Studies Risk National Cancer Institute (U.S.)Predictive Value of Tests Registries Risk Assessment Age Factors Disease-Free Survival Odds Ratio Risk Factors Evaluation Studies as Topic Multivariate Analysis Questionnaires Kaplan-Meier Estimate SEER Program Clinical Trials as Topic Logistic Models American Cancer Society Incidence ROC Curve Genetic Testing Confidence Intervals Treatment Outcome Cluster Analysis Palliative Care Feasibility Studies Age Distribution Prevalence

Geographicals4

United States China Japan Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Early Detection of Cancer Sensitivity and Specificity Limit of Detection Polymerase Chain Reaction Prostatic Neoplasms Breast Neoplasms Ovarian Neoplasms Lung Neoplasms Stomach Neoplasms Colonic Neoplasms Neoplasm Metastasis Neoplasms Reproducibility of Results Neoplasm Invasiveness Pancreatic Neoplasms Gene Expression Regulation, Neoplastic Mice, Nude Reverse Transcriptase Polymerase Chain Reaction Neoplasm Proteins Cancer Vaccines Uterine Cervical Neoplasms Tumor Markers, Biological Prognosis Retrospective Studies Prospective Studies Survival Analysis Mutation Genetic Predisposition to Disease Survival Rate Carcinoma Carcinoma, Squamous Cell Cell Line, Tumor Colorectal Neoplasms Urinary Bladder Neoplasms Disease Progression Follow-Up Studies Gene Expression Profiling Antineoplastic Agents RNA, Messenger Carcinoma, Non-Small-Cell Lung Risk Drug Resistance, Neoplasm Antineoplastic Combined Chemotherapy Protocols Neoplasm Staging National Cancer Institute (U.S.)Molecular Sequence Data Base Sequence Predictive Value of Tests Registries Receptors, Estrogen United States Risk Assessment Genotype DNA, Neoplasm Xenograft Model Antitumor Assays Blotting, Western Neoplasm Recurrence, Local Prostate-Specific Antigen Enzyme-Linked Immunosorbent Assay Receptor, erbB-2 DNA Primers Age Factors Immunoenzyme Techniques Survivors Oligonucleotide Array Sequence Analysis Rectal Neoplasms DNA Methylation Neoplasm Transplantation Mammography Disease-Free Survival Cell Transformation, Neoplastic Antibodies, Monoclonal Odds Ratio Combined Modality Therapy Endometrial Neoplasms Algorithms RNA, Small Interfering Smoking Risk Factors Antigens, Neoplasm Esophageal Neoplasms Tumor Suppressor Protein p53 Cell Survival Time Factors Chemotherapy, Adjuvant Medical Oncology Transplantation, Heterologous Adenocarcinoma Liver Neoplasms Evaluation Studies as Topic Fluorouracil Breast Neoplastic Stem Cells Multivariate Analysis Tamoxifen Polymorphism, Genetic Mouth Neoplasms Receptors, Progesterone Genes, BRCA1 Cisplatin

No FAQ available that match "detection of cancer"